Clinical High Risk for Psychosis (CHR)
Psychiatry·MeSH: Psychotic Disorders
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cannabidiol | Valneva SE (VALN) |
Frequently asked questions
How many drugs are in development for Clinical High Risk for Psychosis (CHR)?
BioSniper tracks 1 drug in development for Clinical High Risk for Psychosis (CHR) across 1 company.
How many clinical trials target Clinical High Risk for Psychosis (CHR)?
There are 2 clinical trials targeting Clinical High Risk for Psychosis (CHR) tracked by BioSniper.
Deep-dive into Clinical High Risk for Psychosis (CHR)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis